Sort
50,496 grants matching “lung cancer”
NIH Chronic GVHD Study Group
$688,357Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Core B. Clinical & Biomarkers Core
$688,272Dorothy K Hatsukami · University Of Minnesota · P01 · FY2025 · CA
Rhesus HHV-8 homologue in AIDS-related malignancies
$688,251Scott W Wong · Oregon Health & Science University · R01 · FY2021 · CA
Functional Genomics of Complex Vascular Disease
$688,223Joseph A. Hill · Ut Southwestern Medical Center · P30 · FY2009 · HL
Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation
$688,198Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2014 · CA
Colorectal Tumor Risk Prediction in the PLCO Trial
$688,181Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA
The Environment and Epigenetic Gene Silencing in Cancer
$688,149Stephen B Baylin · Johns Hopkins University · R01 · FY2008 · ES
PQ1: Identification and characterization of genetic alterations for the progression of pre-neoplastic lung lesions by using novel PDx models and deep sequencing
$688,142David Sidransky · Johns Hopkins University · R01 · FY2016 · CA
Thiol Isomerases and Oxidant Stress in Thrombus Formation
$688,077Robert C Flaumenhaft · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
$688,043Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2018 · CA
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$688,018Benjamin G. Neel · New York University School Of Medicine · R01 · FY2023 · CA
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$688,018Benjamin G. Neel · New York University School Of Medicine · R01 · FY2022 · CA
Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults
$687,995Lisa M Fucito · Yale University · R01 · FY2025 · CA
Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol
$687,896Diane Berengere Re · Columbia University Health Sciences · R01 · FY2021 · ES
Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment
$687,824Lan Zhou · Methodist Hospital Research Institute · R01 · FY2024 · CA
CHARGE consortium: gene discovery for CVD and aging phenotypes
$687,788Bruce M Psaty · University Of Washington · R01 · FY2019 · HL
Protein Tyrosine Dephosphorylation & Signal Transduction
$687,770Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2011 · CA
Engineering Dual-Targeted Nanoplatforms to Effectively Treat NSCLC.
$687,752Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2022 · EB
Multifunctional nanoparticles for enhanced drug delivery to the lung
$687,734Hugh David Smyth · University Of Texas At Austin · R33 · FY2013 · HL
Statistical Informatics for Cancer Research
$687,641Xihong Lin · Harvard School Of Public Health · P01 · FY2014 · CA
A randomized trial of charcoal-filtered cigarettes on product perceptions, smoking behaviors, and toxicant exposure
$687,511Melissa Mercincavage · Rutgers Biomedical And Health Sciences · R37 · FY2025 · CA
Project 1: Effects of unventilated filters on pattern of cigarette use, toxicant exposure and uptake of alternative nicotine products
$687,505Dorothy K Hatsukami · University Of Minnesota · P01 · FY2019 · CA
Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome
$687,433Anthony Shum · University Of California, San Francisco · R01 · FY2023 · AI
Negative regulation of innate immunity in influenza virus infection
$687,400Jian-Dong Li · Georgia State University · R01 · FY2025 · AI
Functional consequences of cancer mutations
$687,395Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA